Akums Drugs and Pharmaceuticals Limited

Akums Drugs and Pharmaceuticals Limited (AKUMS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

akums.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹780.55
Market cap
11,954 Cr
Stock P/E
40.8
P/B
3.59

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,019 Cr1,033 Cr1,010 Cr1,056 Cr1,024 Cr1,018 Cr1,160 Cr1,158 Cr1,167 Cr
Operating expenses (approx.)891 Cr912 Cr889 Cr962 Cr895 Cr923 Cr1,013 Cr1,006 Cr992 Cr
EBITDA128 Cr121 Cr121 Cr94 Cr129 Cr94 Cr147 Cr152 Cr175 Cr
OPM %12.6%11.7%12.0%8.9%12.6%9.3%12.7%13.1%15.0%
Other income7 Cr13 Cr15 Cr18 Cr27 Cr32 Cr34 Cr35 Cr30 Cr
Interest13 Cr12 Cr5 Cr5 Cr23 Cr23 Cr24 Cr24 Cr25 Cr
Depreciation34 Cr35 Cr45 Cr40 Cr37 Cr38 Cr40 Cr40 Cr41 Cr
Profit before tax87 Cr92 Cr91 Cr75 Cr96 Cr66 Cr100 Cr121 Cr139 Cr
Tax %30.0%27.2%27.2%-99.1%32.4%35.0%32.0%32.9%27.5%
Net profit61 Cr67 Cr66 Cr150 Cr65 Cr43 Cr68 Cr81 Cr101 Cr
EPS (₹)₹4.21₹4.37₹4.26₹9.64₹4.15₹2.66₹4.33₹5.53₹6.53

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025Mar 2026TTM
Sales4,118 Cr4,359 CrSign in for TTM
Operating expenses (approx.)3,654 Cr3,837 CrSign in for TTM
EBITDA464 Cr522 CrSign in for TTM
OPM %11.3%12.0%Sign in for TTM
Other income52 Cr129 CrSign in for TTM
Interest35 Cr94 CrSign in for TTM
Depreciation153 Cr155 CrSign in for TTM
Profit before tax345 Cr382 CrSign in for TTM
Tax %0.4%32.9%Sign in for TTM
Net profit344 Cr256 CrSign in for TTM
EPS (₹)₹22.60₹16.67Sign in for TTM
Dividend payout %0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025Mar 2026
Equity capital31 Cr31 Cr
Reserves3,016 Cr3,283 Cr
Borrowings14 Cr73 Cr
Other liabilities1,036 Cr2,043 Cr
Total liabilities4,113 Cr5,447 Cr
Fixed assets (net)1,390 Cr1,448 Cr
CWIP160 Cr177 Cr
Investments0.14 Cr0.14 Cr
Inventories681 Cr756 Cr
Trade receivables770 Cr797 Cr
Cash & bank101 Cr386 Cr
Other assets1,011 Cr1,884 Cr
Total assets4,113 Cr5,447 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025Mar 2026
Cash from operating activity465 Cr1,181 Cr
Cash from investing-548 Cr-930 Cr
Cash from financing73 Cr34 Cr
Net cash flow-10 Cr285 Cr
Free cash flow (OCF − Capex)193 Cr951 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025Mar 2026
ROCE %12.3%14.0%
ROE %11.0%7.7%
Debtor days6867
Inventory days110120
Days payable10495
Cash conversion cycle7491
Debt / equity0.00450.02
Current ratio2.553.25
Net debt / EBITDA-0.19-0.60

Compare with peers

Loading peers…